Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
EBIATLong-Term Debt RepaymentsShares Issued
Ratios

Solid Biosciences (SLDB) Shares Outstanding (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Shares Outstanding for 8 consecutive years, with $38.9 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding rose 94.05% to $38.9 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $38.9 million through Sep 2024, up 94.05% year-over-year, with the annual reading at $20.4 million for FY2023, 4.24% up from the prior year.
  • Shares Outstanding hit $38.9 million in Q3 2024 for Solid Biosciences, up from $38.6 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $112.4 million in Q1 2021 to a low of $5.8 million in Q4 2020.
  • Historically, Shares Outstanding has averaged $27.6 million across 5 years, with a median of $20.0 million in 2023.
  • Biggest five-year swings in Shares Outstanding: crashed 93.31% in 2022 and later skyrocketed 166.32% in 2023.
  • Year by year, Shares Outstanding stood at $5.8 million in 2020, then increased by 29.23% to $7.5 million in 2021, then soared by 160.76% to $19.6 million in 2022, then increased by 4.24% to $20.4 million in 2023, then soared by 90.96% to $38.9 million in 2024.
  • Business Quant data shows Shares Outstanding for SLDB at $38.9 million in Q3 2024, $38.6 million in Q2 2024, and $37.8 million in Q1 2024.